Myriad Genetics
MYGN
MYGN
235 hedge funds and large institutions have $2.14B invested in Myriad Genetics in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 92 increasing their positions, 75 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
235
Holders Change
-27
Holders Change %
-10.31%
% of All Funds
5.11%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
22
Increased
92
Reduced
75
Closed
45
Calls
$21.2M
Puts
$25.7M
Net Calls
-$4.46M
Net Calls Change
+$28.4M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$47.7M |
| 2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$18.7M |
| 3 |
3
BlackRock
New York
|
$348M |
| 4 |
4
Point72 Asset Management
Stamford,
Connecticut
|
$27.3M |
| 5 |
5
Morgan Stanley
New York
|
$13.1M |
